Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone in Resistant Arterial Hypertension
NCT00524615Phase 4Unknown
- Start
- Sep 2007
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of spironolactone in resistant hypertension (RH). Status: unknown.
02
Drugs
spironolactone
03
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on NCT00524615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00524615.